Latigo Biotherapeutics, Inc. (LTGO)

SEC filing

Latigo Biotherapeutics, Inc.

LTGO · CIK 2056611

4 · Aug 10, 2026 · Foresite Capital Fund VI LP bought 140K shares at $18.00/share ($2.5M); converted 9.04M shares

Foresite Capital Fund VI LP bought 140K shares at $18.00/share ($2.5M); converted 9.04M shares

OWNERSHIP DOCUMENT

xslF345X06/tm2622773-1_4seq1.xmlSEC.gov

Graphics and non-inline formats (not embedded below).